OpenURL Connection Search

Select item for more details and to access through your institution.

Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia.
Published in:
Clinical Lymphoma, Myeloma & Leukemia, 2010, v. 10, n. 3, p. 211, doi. 10.3816/CLML.2010.n.033
By:
- Rizzieri, David;
- LoRusso, Samantha;
- Tse, William;
- Khan, Khuda;
- Advani, Anjali;
- Moore, Joseph;
- Karsten, Verena;
- Cahill, Ann;
- Gerson, Stanton L.
Publication type:
Article
Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects.
Published in:
Clinical Pharmacology & Therapeutics, 2021, v. 109, n. 2, p. 372, doi. 10.1002/cpt.1974
By:
- Habtemariam, Bahru A.;
- Karsten, Verena;
- Attarwala, Husain;
- Goel, Varun;
- Melch, Megan;
- Clausen, Valerie A.;
- Garg, Pushkal;
- Vaishnaw, Akshay K.;
- Sweetser, Marianne T.;
- Robbie, Gabriel J.;
- Vest, John
Publication type:
Article
Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Published in:
2020
By:
- Judge, Daniel P.;
- Kristen, Arnt V.;
- Grogan, Martha;
- Maurer, Mathew S.;
- Falk, Rodney H.;
- Hanna, Mazen;
- Gillmore, Julian;
- Garg, Pushkal;
- Vaishnaw, Akshay K.;
- Harrop, Jamie;
- Powell, Christine;
- Karsten, Verena;
- Zhang, Xiaoping;
- Sweetser, Marianne T.;
- Vest, John;
- Hawkins, Philip N.
Publication type:
Correction Notice
Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).
Published in:
Cardiovascular Drugs & Therapy, 2020, v. 34, n. 3, p. 357, doi. 10.1007/s10557-019-06919-4
By:
- Judge, Daniel P.;
- Kristen, Arnt V.;
- Grogan, Martha;
- Maurer, Mathew S.;
- Falk, Rodney H.;
- Hanna, Mazen;
- Gillmore, Julian;
- Garg, Pushkal;
- Vaishnaw, Akshay K.;
- Harrop, Jamie;
- Powell, Christine;
- Karsten, Verena;
- Zhang, Xiaoping;
- Sweetser, Marianne T.;
- Vest, John;
- Hawkins, Philip N.
Publication type:
Article

Found: 4

Phase I Study of Temozolomide and Laromustine (VNP40101M) in Patients With Relapsed or Refractory Leukemia.

Single‐Dose Pharmacokinetics and Pharmacodynamics of Transthyretin Targeting N‐acetylgalactosamine–Small Interfering Ribonucleic Acid Conjugate, Vutrisiran, in Healthy Subjects.

Correction to: Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR).